Migration and proliferation of smooth muscle cells are key to a number of physiological and pathological processes, including wound healing and the narrowing of the vessel wall. Previous work has shown links between inflammatory stimuli and vascular smooth muscle cell proliferation and migration through mitogen activated protein kinase (MAPK) activation, though the molecular mechanisms of this process are poorly understood. Here we report that tribbles-1, a recently described modulator of MAPK activation controls vascular smooth muscle cell proliferation and chemotaxis via the Jun Kinase pathway. Our findings demonstrate that this regulation takes place via direct interactions between tribbles-1 and MKK4/SEK1, a Jun activator kinase. The activity of this kinase is dependent on tribbles-1 levels, whilst the activation and the expression of MKK4/SEK1 is not. In addition, tribbles-1 expression is elevated in human atherosclerotic arteries compared to non-atherosclerotic controls, suggesting that this protein may pay a role in disease in vivo. In summary, the data presented here suggest an important regulatory role for trb-1 in vascular smooth muscle cell biology.
Injury to the arterial wall initiates a series of changes in specialised molecular and cellular events that not only contribute to wound healing but to the pathogenesis of atherosclerosis, the presentation of acute coronary syndromes (ACS) and the complications of percutaneous coronary intervention (PCI). An important initiating event appears to be endothelial cell dysfunction or cell death caused by local abnormalities. These events result in the production and release of a number of inflammatory cytokines and chemokines. In pathogenic conditions, elevated levels of inflammatory mediators can lead to migration and proliferation of vascular smooth muscle cells (VSMC) to form a neointima. These cellular responses are mediated via the co-ordinated action of various second messenger pathways, including activation of Mitogen Activated Protein Kinase (MAPK) cascades and IκB kinases. Activation of these systems has been reported in several pathological conditions of vessel walls (1) (2) (3) . MAPKs are involved in the regulation of development, cell activation, proliferation and vascular contraction (4) (5) (6) (7) . Further, they are central in regulating VSMC activation. It has been demonstrated that activation of MAPK cascades occurs in response to a wide range of stimuli, including pro-inflammatory cytokines, growth factors, mechanical stimuli (stress) (8) and integrindependent cell/matrix interactions (9, 10) . MAPKs are classified into at least three distinct groups (JNK, p38 and ERK kinases) and can be activated via a variety of upstream kinases, MAPKKs. In VSMC, Jun kinases (JNK) and p38 MAPKs have been implicated in responses primarily to stress (heat, hypoxia, chemical, oxidative, etc.) and proinflammatory cytokines, extracellular signal regulated protein kinases (ERK) primarily respond to mitogenic stimuli such as growth factors (PDGF) (11) , oxidised LDL (12) or Ang II (reviewed in (13) ). However, in most cases a given stimulus will activate more than one group of MAPKs. The specific contribution of each MAPK pathway to a physiological response varies from cell type to cell type. In some cases, MAPK pathways can cooperate, but they can antagonise in others (14, 15) . However, the mechanisms which are responsible for these differences in MAPK responses in VSMC are largely unknown.
We have recently reported the identification (16, 17) and characterisation of a novel protein family, human tribbles (trb) as regulators of MAPKK activity (16, 18) . We have shown that trb-1 and trb-3 are able to bind to various MAPKKs and that their concentration regulates preferential activation of the different MAPK pathways, presumably leading to different cellular responses (18) . Drosophila and Xenopus Tribbles have been shown to regulate cell cycle progression during embryonic development (19) (20) (21) (22) . Murine trb-3 has been demonstrated to inhibit insulin-dependent activation of Akt and was suggested to play a role in the development of diabetes in a mouse model (23, 24) . However, recent conflicting data suggest that this proposed role may require further clarification (25) . Further, the importance of human tribbles proteins in cell physiology has not been evaluated. Here we report that trb-1 is selectively overexpressed in chronically inflamed human atherosclerotic arteries and that it regulates vascular smooth muscle cell proliferation and chemotaxis via the JNK pathway. These observations define trb-1 as a novel, central regulator of VSMC function.
EXPERIMENTAL PROCEDURES All the experiments described in this study were performed multiple times (N>2) and representative datasets are shown.
Ethics:
The human samples were obtained under the ethical approval granted by the North Sheffield Research Ethics Committee. This study conforms to the principles outlined in the Declaration of Helsinki.
Plasmids, siRNA
Trb-1 overexpression plasmid has been described before (18) . siRNA SmartPool against human trb-1 was purchased from Dharmacon and used according to the manufacturer's recommendation.
Plasmids for yellow fluorescent protein (YFP)-based protein fragment complementation assay (PCA) (42, 43) were a kind gift of Prof. S. Michnik and have been described before (26) .
Cell culture and the stimulation with LPS VSMC were purchased from Cascade Biologics and maintained in Medium 231 with smooth muscle growth supplement (all from Cascade Biologics). VSMC were plated in 6 well plates at an initial density of 0.5×10 5 cells/well in 2 ml of complete growth media. 24 hours post transfection cells were stimulated by 100 ng/ml LPS, as stated in the figures. HeLa cells (ATCC) were maintained in DMEM medium (Invitrogen), containing 10% Foetal Bovine Serum (Biowhittaker), 5mM of sodium pyruvate and 100 µg/ml of penicillin and streptomycin (Sigma).
Artery biopsies
Coronary arteries from patients with a diagnosis of ischemic heart disease (IHD, n=8) and dilated cardiomyopathy (DCM, n=6) were harvested from transplantation recipients at the time of surgery. Patients diagnosed as having DCM were free of CAD before transplantation, as assessed by coronary angiography and histological analysis by a cardiac pathologist (SKS) using the American Heart Association (AHA) classification system (27) (28) (29) . All patients were men and white in origin. Mean ages were 55.75 ±5.11 for IHD and 48.5±10.23 for the DCM group. Mean AHA histological grades of disease were 6.42 for the IHD and 3.16 for the DCM group, respectively.
RNA isolation and Quantitative Real-time PCR analysis
Total RNA was extracted from human artery biopsies and VSMC using RNeasy kit (Qiagen) according to the manufacturer's protocol. 2µg RNA was reverse transcribed into first strand cDNA and used immediately for qRT-PCR. Gene expression was analyzed by qRT-PCR using ABI prism 7900 (Applied Biosystems). Probes for human trbs, IL-1 , IL-RA, TNF and GAPDH were synthesized by Sigma Genosys with FAM at the 5'-end and TAMRA at the 3'-end. The sequences of all primers and probes used are listed below. In Vitro wound healing assay, Time Lapse VideoMicroscopy (TLVM): Cells were transfected as described above, seeded into 35mm culture dishes and incubated overnight. Confluent cell monolayers were wounded by removing a strip of cells from the plate surface with a standard 1ml pipette tip. Wounded monolayers were washed with PBS to remove non-adherent cells and replaced with fresh complete growth medium. TLVM (30, 31) was used to film migration at the wound edges for 24 hours (1 frame every 2.5minutes). The number of cells crossing a line marking the wound edges was counted over the 24 hour period. (Fig. 2D ) 15 randomly picked cells from the wound edges were tracked over a 1 hour period. The on-screen distance travelled was measured to calculate migration speed (mm/h) irrespective of direction. (Fig. 2E) 
Western blotting:
Anti-phospho-MAPK and anti-MAPK antibodies were purchased from Cell Signalling Technology and were used according to the manufacturer's recommendations. Anti-β-actin antibody was from Dako. Between probing for the various proteins, membranes were stripped by Re-Blot Plus Mild solution (Chemicon). Membranes were developed with SuperSignal West Pico Chemiluminescent Substrate and signals were quantified by Chemigenius geldocumentation system (Syngene). pMAPK and MAPK signals were expressed as a ratio to β-actin levels within the same sample.
Immunostainning
Serial 4µm thick paraffin-embedded human artery sections were stained for Trb-1 using standard techniques. Trb-1 primary antibody (Millipore-Upstate) was applied overnight at 4 o C. Sections were then exposed to goat biotinylated anti-rabbit secondary antibody (Vector laboratories) for 30 minutes at room temperature. Vectastain ABC reagent (Vector Laboratories) was added and incubated at room temperature for 30 min. Slides were then immersed in 0.25 mg/ml 3,3'diaminobenzidine, activated with hydrogen peroxide and counterstained with Carazzi's hematoxylin. Primary antibody was omitted from the negative controls.
RESULTS

Tribbles expression is regulated in response to an inflammatory stimulus in hASMC
Smooth Muscle Cell proliferation is a key event in the healing response to injury, a process which is initiated by inflammatory stimuli (32) . To identify whether tribbles expression is regulated in vascular cells under inflammatory conditions, we stimulated human aortic smooth muscle cells (hASMC, Fig. 1A ) and human umbilical vein endothelial cells (HUVEC, not shown) with LPS and measured tribbles mRNA expression levels by using qRT-PCR. IL-1β expression was measured as positive controls in the same samples (Fig. 1B) . We found that trb-1 was selectively and transiently up-regulated by LPS treatment in hASMC (Fig. 1A) but not in HUVEC (not shown). Previous reports (33) and our unpublished observations suggest that tribbles proteins may be unstable and expressed at low levels, therefore, mRNA levels are likely to correlate well with protein expression. We have, therefore, investigated the biological relevance of altered trb-1 levels on hASMC under inflammatory conditions. To assess the role of trb-1 in LPS stimulated hASMC, we transiently transfected these cells with a trb-1 expression plasmid or a pool of anti-trb-1 siRNA oligonucleotides and measured proliferation and migration in response to PDGF. However, first we evaluated the potential impact of culture conditions on trb-1 expression (Fig. 1C) and the specificity of the siRNA pool (Fig. 1D ) used for targeting trb-1 mRNA. We have found that whilst trb-1 siRNA had the desired activity both under standard culture conditions (10% FCS) and when cells were serum starved post-transfection (0.5%), the expression levels of this gene and, indeed, the other tribbles as well (not shown) were significantly affected by the serum concentration. This is in line with previous work, demonstrating that expression of members of mammalian trb family is modulated through metabolic signals (34, 35) . Therefore, we have used 10% FCS in all our experiments in order to minimise inter-experimental variations. In addition, the siRNA pools showed high specificity towards trb-1 and did not alter significantly trb-2 and -3 expression (Fig. 1D ). In line with these results, siTrb-1 treatment resulted in a substantial decrease in trb-1 protein levels (Fig. 1E) 
Tribbles-1 regulate specific hASMC cellular functions
To investigate the role of trb-1 in hASMC function, we raised or suppressed trb-1 levels by transient transfection of hASMC cells with trb-1 expression plasmid or siRNA and measured proliferation by 3 H-thymidine incorporation ( Fig.  2A-B) . We observed a modest anti-proliferative effect at 48 hrs post-transfection (24 hrs time point in the proliferation assay) when trb-1 was overexpressed. In contrast, depletion of trb-1 results in a significant increase in proliferation rate at the same time-point (Fig. 2B) . However, this assay measures the net effect of cell death and proliferation. In order to confirm that the observed increase in 3 H-thymidine incorporation is due to an increased mitosis rate, we performed time lapse video imaging on control and si-trb-1 treated cells and calculated the rate of mitosis (Fig. 2C ). The data obtained by both methods was in agreement. In addition, there was not difference in the observed rate of apoptosis between treatment, further supporting a specific tribbles effect on proliferation. Using the same time lapse assay, we also measured VSMC migration in a "wound healing" assay. (Fig. 2D, E) . These data show that neither the number of cells migrating into the wound (Fig. 2D) nor their migration speed (Fig. 2E) were affected upon depletion of trb-1. As trb-1 acts via modulating MAPK activation and this signalling system is known to govern VSMC proliferation, we used selective MAPK inhibitors to block individual pathways and investigated their involvement in the trb-1 regulated proliferation (Fig. 2F ). These data demonstrate that blocking of JNK but not p38 pathways suppresses VSMC proliferation. In line with previous reports, inhibiting ERK activation also caused a significant inhibition of proliferation (36) . To further investigate the impact of trb-1 levels in hASMC function, chemotaxic migration of these cells was measured in a transwell migration assay, in response to PDGF (Fig. 2G) . Depletion of trb-1 led to an increase in transmigrated cells. Further, inhibition of the JNK pathway abrogated the effect of si-trb-1 treatment, suggesting that trb-1 may be a negative regulator of hASMC chemotaxis via inhibitory activity of the JNK pathway. Activation of Vascular Smooth Muscle Cells by inflammatory signals leads to the production of a number of cytokines, including TNFα and TGFβ through MAPK mediated signalling events (37) (38) (39) (40) (41) . We, therefore, investigated whether depletion of trb-1 had a modulator role in the production of these inflammatory cytokines, in VSMC. Our data show no difference in the dynamics or the amplitude of cytokine expression at the TNFα mRNA (Fig.  2H) and TGFβ protein levels (Fig. 2I) , implying that trb-1 may be a specific regulator of VSMC proliferation and migration.
Overexpressed Trb-1 blocks AP-1 activation and Trb-1 depletion leads to constitutive JNK activation In order to gain mechanistic insight into the regulation of VSMC proliferation via the JNK/AP-1 pathways and trb-1, VSMC was transiently transfected with an AP-1 reporter plasmid, activated by overexpressed MEKK1 in the presence and absence of overexpressed trb-1 (Fig.  3A) . The results demonstrate that activation of AP-1 can be blocked by overexpressed trb-1 in VSMC, in line with our previous report in HeLa cells (18) . Next, the activation of the various MAPKs were assessed in control and trb-1 depleted cells. Phosphorylated MAPK (pMAPK, the activated form) and total MAPK levels were investigated in response to LPS treatment, by western blotting. pMAPK (Fig. 3B ) and total MAPK (Fig. 3C ) levels were normalised to β-actin and expressed as relative units. In agreement with our previous report (18) , alterations in trb-1 levels had a differential impact on the various MAPK pathways. However, these effects were different in VSMCs, compared to those observed in HeLa cells (18) . In VSMC, the amount of phospho-p38 protein but not the dynamics of activation was influenced by altered trb-1 expression. In contrast, while ERK and JNK pathways were also sensitive to altered trb-1 expression, these were no longer up-regulated by LPS stimulation. Indeed, modulation of trb-1 expression caused phosphorylation of both of MAPKs to decrease, once stimulated. In addition, depletion of trb-1 mRNA by the siRNA constructs led to an increase in phosphorylation of JNK in the absence of any stimulus (Fig. 3B , middle graph, zero time point), suggesting that normal trb-1 levels inhibit the activation of this pathway in the nonstimulated state. However, no significant alterations in total MAPK levels were observed in cells, where trb-1 levels were perturbed (Fig. 3C ). These observations are compatible with the hypothesis that MAPK scaffold levels are key determinants of pathway activation (42) and that tribbles may have a scaffold-like function as proposed previously (18) . According to these models, both up and downregulation of scaffold levels may lead to impaired activation of signalling systems. We have seen such effects on the JNK and ERK pathways in VSMC, similarly to our previous studies on HeLa cells (18) .
Trb-1/MKK4 interaction is key to the regulation of hASMC proliferation
We have previously shown in biochemical assays that tribbles proteins interact with MAPKKs and regulate their activity (18) . However, since many aspects of tribbles action appear to be cell type specific (for recent reviews see (43, 44)), we set out to investigate details of trb/MAPKK interactions in hASMC. Our data point to the JNK pathway as a key system in regulating proliferation and chemotaxis in these cells, in a trb-1 dependent manner. Therefore, we characterised the involvement of MKK4/SEK-1 and MKK7, the two known MAPKKs, which lead to activation of JNK. Our results show that MKK4 but not MKK7 is expressed in these cells and that this expression pattern is not influenced by sitrb-1 treatment ( Figure 4A ). We also found that the phosphorylation of MKK4 was not affected by depletion of trb-1 ( Figure 4B ), suggesting that trb-1 directly interferes with MKK4 activity, rather than with activation and/or expression. To confirm the direct role of MKK4 in hASMC proliferation, we performed a [ 3 H] thymidine incorporation assay in siMKK4 treated cells ( Figure 4C ), as before. In line with our above model, the data demonstrate a positive role for MKK4, since depletion of this protein led to a decrease in proliferation rate.
To confirm the physical interaction between trb-1 and MKK4 in live hASMC, we used a yellow fluorescent protein (YFP)-based protein fragment complementation assay (PCA) (45, 46) and co-immunoprecipitation. The Venus variant of YFP was used in this assay, since it provides a higher signal than EYFP. MKK4 and Trb-1 were fused to the N-terminal fragment of Venus YFP (V1) or to the C-terminal portion of Venus YFP (V2), respectively. The two expression constructs were co-transfected and the YFP signal was visualised by fluorescent microscopy ( Figure 4D ). These data demonstrate that the MKK4/trb-1 complex is located predominantly in the nucleus of hASMC. In line with this finding, a co-immunoprecipitation experiment further confirmed the interaction between MKK4 and trb-1 (Fig. 4E) .
We have shown recently that the Nterminal region of trb-1 governs the intracellular localisation of the protein (17) . We wondered, therefore, whether the same domain influenced the location of the MKK4/trb-1 complex. Truncated trb-1 forms, lacking the N-terminal, the C-terminal or both domains ( Figure 4F ) were expressed as V2 fusion proteins ( Figure 4E) . The results show that the nuclear localisation of the complex is critically dependent on the presence of the N-terminal trb-1 domain. Mutants lacking this domain still showed an interaction with MKK4, but the signal was no longer preferentially nuclear.
Further, these experiments demonstrate that the central, kinase-like domain of trb-1 is sufficient for interaction with MKK4. This is in line with our previous report, where we showed that expression of this domain was sufficient to inhibit of AP-1 activation via trb-1 (17) .
In order to confirm specificity of the observed interaction, several control experiments were performed. Co-expression of an increasing amount of "unlabelled" trb-1 led to a dosedependent elimination of the YFP signal as detected by FACS ( Figure 4G ) or by fluorescent microscopy ( Figure 4H ). In addition, neither MKK4-Venus nor trb-1-Venus fusion proteins interacted with their zipVenus counterparts (these were used as positive control constructs in the system) ( Figure 4G ), which further supports the specific nature of this interaction.
Tribbles-1 expression in atherosclerotic arteries
Proliferation of vascular smooth muscle cells is one of the hallmarks of the development of chronic diseases of the vessel wall. In order to evaluate the potential role of tribbles in human disease, we studied segments of whole artery wall taken from the explanted hearts of patients undergoing cardiac transplantation for ischaemic heart disease (IHD) and characterised tribbles expression. Coronary arteries from patients with non-ischaemic dilated cardiomyopathy (DCM) were used as controls. In order to quantify potential differences in trb expression levels between the two groups, mRNA levels of known pro and antiinflammatory cytokines (IL-1β and IL-1ra) and tribbles 1-3 were quantified by using qRT-PCR (Fig.  5) . As in our previous work (47), we detected a "proinflammatory phenotype" in the atherosclerotic group. Expression of trb-1 but not of trb-2 was significantly raised in the IHD group (Fig. 5A) , whilst trb-3 expression was not detected in these samples (not shown).
In order to visualise trb-1 expression in vivo, sections of a human coronary artery were stained by anti-trb1 antibody (Fig. 5B) . The majority of trb-1 specific staining was detected in the intimal and medial areas. Of note, nuclear and/or cytoplasmic trb-1 staining was observed in medial VSMC.
DISCUSSION
In this paper, we have evaluated the importance of tribbles proteins, particularly trb-1 in the cellular responses of vascular smooth muscle cells to inflammatory stimuli. Taken together, our experiments demonstrate that trb-1 is found in VSMC in vivo and that expression levels are key in modulating the extent of VSMC proliferation and chemotaxis. In contrast, VSMC migration speed in a "wound healing" assay and the production of cytokines are not affected by altered trb-1 levels, suggesting a specific physiological role for this protein.
Whilst a body of literature supports the involvement of ERK and JNK MAPK pathways in VSMC chemotaxis, the role of these second messenger systems in wound healing assays (in the absence of chemokines) is much less understood. Our data implies that the two processes might be differentially regulated. However, further detailed studies will be needed to clarify this.
Blockade of specific MAPK pathways by pharmacological inhibitors pointed to the JNK pathway as a major regulator of VSMC proliferation. In line with the model where trb-1 controls JNK activation, we found that si-trb-1 treatment of VSMC led to the spontaneous activation of JNK ( Figure 3B ). Therefore, we have investigated the detail of the interaction between JNK activating kinases and trb-1. Of the MAPK kinases, which are known to activate JNK, MKK4 but not MKK7 was found to be expressed in VSMC. Using a recently developed technique (PCA), we were able to visualise the interaction between trb-1 and MKK4 in live VSMC cells. To our knowledge, this is the first use of this powerful technique in studies of primary vascular cells. A number of controls demonstrate the specificity of the observed interaction. Further, we were able to show that the intracellular localisation of the trb-1/MKK4 complex is dependent on the N-terminal domain of trb-1. This is in line with our previous findings where we demonstrated that the N-terminal domain of trb-1 is essential for nuclear localisation. However, clarification of the functional relevance of this observation requires further studies. The use of truncated trb-1 proteins in PCA demonstrates that the kinase-like domain of trb-1 is essential for it's ability to interact with MAPKKs. Since this domain is similar to that of the MAPKs (MAPKK substrates), a plausible hypothesis for the molecular mechanism of trb action is that tribbles may compete for the binding site with the MAPKs, thus regulating their activation. This model may explain why evolution preserved a catalytically inactive kinase domain from unicellular organisms to mammals (43, 44). 
